Ki R. Kim
Sangju, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Platycodin D Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Blocking the Activation of Mitogen-Activated Protein Kinases and the Production of Interleukin-8.
Journal: The American journal of Chinese medicine
Published: July 18, 2022
Transforming growth factor-β-regulated fractalkine as a marker of erosive bone invasion in oral squamous cell carcinoma.
Journal: European journal of oral sciences
Published: July 13, 2020
Chemerin Treatment Inhibits the Growth and Bone Invasion of Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: March 16, 2020
CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
Journal: The Journal of clinical investigation
Published: October 12, 2018
Liensinine and Nuciferine, Bioactive Components of Nelumbo nucifera, Inhibit the Growth of Breast Cancer Cells and Breast Cancer-Associated Bone Loss.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 26, 2017
Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.
Journal: Scientific reports
Published: April 11, 2017
Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts.
Journal: Scientific reports
Published: November 14, 2016
Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.
Journal: Journal of cancer prevention
Published: November 25, 2015
Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Journal: Oncotarget
Published: October 08, 2015
Platycodin D Blocks Breast Cancer-Induced Bone Destruction by Inhibiting Osteoclastogenesis and the Growth of Breast Cancer Cells.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: May 28, 2015
Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer.
Journal: The Journal of pathology
Published: December 22, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026